Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community

To evaluate the performance of nasal mid-turbinate self-testing using rapid antigen detection tests (RDT) for persons with suspected coronavirus disease 2019 (COVID-19) in the community. Self-testing for COVID-19 infection with lateral flow assay severe acute respiratory syndrome coronavirus 2 (SARS...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical microbiology and infection 2022-05, Vol.28 (5), p.695-700
Hauptverfasser: Stohr, Joep J.J.M., Zwart, Vivian F., Goderski, Gabriel, Meijer, Adam, Nagel-Imming, Carla R.S., Kluytmans-van den Bergh, Marjolein F.Q., Pas, Suzan D., van den Oetelaar, Femke, Hellwich, Marloes, Gan, Kim H., Rietveld, Ariene, Verweij, Jaco J., Murk, Jean-Luc, van den Bijllaardt, Wouter, Kluytmans, Jan A.J.W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 700
container_issue 5
container_start_page 695
container_title Clinical microbiology and infection
container_volume 28
creator Stohr, Joep J.J.M.
Zwart, Vivian F.
Goderski, Gabriel
Meijer, Adam
Nagel-Imming, Carla R.S.
Kluytmans-van den Bergh, Marjolein F.Q.
Pas, Suzan D.
van den Oetelaar, Femke
Hellwich, Marloes
Gan, Kim H.
Rietveld, Ariene
Verweij, Jaco J.
Murk, Jean-Luc
van den Bijllaardt, Wouter
Kluytmans, Jan A.J.W.
description To evaluate the performance of nasal mid-turbinate self-testing using rapid antigen detection tests (RDT) for persons with suspected coronavirus disease 2019 (COVID-19) in the community. Self-testing for COVID-19 infection with lateral flow assay severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RDT, provides rapid results and could enable frequent and extensive testing in the community, thereby improving the control of SARS-CoV-2. Participants visiting a municipal SARS-CoV-2 testing centre, received self-testing kits containing either the BD Veritor System (BD-RDT) or Roche SARS-CoV-2 antigen detection test (Roche-RDT). Oro-nasopharyngeal swabs were collected from the participants for quantitative RT-PCR (qRT-PCR) testing. As a proxy for contagiousness, viral culture was performed on a selection of qRT-PCR positive samples to determine the Ct-value at which the chance of a positive culture dropped below 0.5 (Ct-value cut-off). Sensitivity and specificity of self-testing were compared to qRT-PCR with a Ct-value below the Ct value cut-off. Determinants independently associated with a false-negative self-test result were determined. A total of 3201 participants were included (BD-RDT n = 1595; Roche-RDT n = 1606). Sensitivity and specificity of self-testing compared with the qRT-PCR results with a Ct-value below the Ct-value cut-off were 78.4% (95% CI 73.2%–83.5%) and 99.4% (95% CI 99.1%–99.7%), respectively. A higher age was independently associated with a false-negative self-testing result with an odds ratio of 1.024 (95% CI 1.003–1.044). Self-testing using currently available RDT has a high specificity and relatively high sensitivity to identify individuals with a high probability of contagiousness.
doi_str_mv 10.1016/j.cmi.2021.07.039
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8336990</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1198743X21004341</els_id><sourcerecordid>2559430483</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-638f8ca9af1d261b281dc4bdb5740bf2b1f24d084160641d3a2de171a51bc8b03</originalsourceid><addsrcrecordid>eNp9kUuLFDEUhYMoztj6A9xIlm6qzKseQRCG9jUwMGDr4C6k8uhOU5WUSWpk1v5x09PtoBtXuSTnfDf3HgBeYlRjhNs3-1pNriaI4Bp1NaL8ETjHrOUVajl-XGrM-6pj9PsZeJbSHiFEKGVPwRlltKWcNefg18aMtsomZee30IYI885AbbJR2QUPg4Wbiy-bah1uKgKdt6f7ny7vYJSz01D67LbGwwMk3SNmE-bRHDVpSXPxGA3X1zeX7yvMC-W-iQrTtHiX756DJ1aOybw4nSvw7eOHr-vP1dX1p8v1xVWlWINz1dLe9kpyabEmLR5Ij7Vigx6ajqHBkgFbwjTqGW5Ry7CmkmiDOywbPKh-QHQF3h258zJMRivjc5SjmKObZLwTQTrx74t3O7ENt6KntOX8AHh9AsTwYynjisklZcZRehOWJEjTcEYRK_oVwEepiiGlaOxDG4zEITyxFyU8cQhPoE6U8Irn1d__e3D8SasI3h4Fpmzp1pkoknLGK6NdLDsWOrj_4H8D9rasDQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2559430483</pqid></control><display><type>article</type><title>Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Stohr, Joep J.J.M. ; Zwart, Vivian F. ; Goderski, Gabriel ; Meijer, Adam ; Nagel-Imming, Carla R.S. ; Kluytmans-van den Bergh, Marjolein F.Q. ; Pas, Suzan D. ; van den Oetelaar, Femke ; Hellwich, Marloes ; Gan, Kim H. ; Rietveld, Ariene ; Verweij, Jaco J. ; Murk, Jean-Luc ; van den Bijllaardt, Wouter ; Kluytmans, Jan A.J.W.</creator><creatorcontrib>Stohr, Joep J.J.M. ; Zwart, Vivian F. ; Goderski, Gabriel ; Meijer, Adam ; Nagel-Imming, Carla R.S. ; Kluytmans-van den Bergh, Marjolein F.Q. ; Pas, Suzan D. ; van den Oetelaar, Femke ; Hellwich, Marloes ; Gan, Kim H. ; Rietveld, Ariene ; Verweij, Jaco J. ; Murk, Jean-Luc ; van den Bijllaardt, Wouter ; Kluytmans, Jan A.J.W.</creatorcontrib><description>To evaluate the performance of nasal mid-turbinate self-testing using rapid antigen detection tests (RDT) for persons with suspected coronavirus disease 2019 (COVID-19) in the community. Self-testing for COVID-19 infection with lateral flow assay severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RDT, provides rapid results and could enable frequent and extensive testing in the community, thereby improving the control of SARS-CoV-2. Participants visiting a municipal SARS-CoV-2 testing centre, received self-testing kits containing either the BD Veritor System (BD-RDT) or Roche SARS-CoV-2 antigen detection test (Roche-RDT). Oro-nasopharyngeal swabs were collected from the participants for quantitative RT-PCR (qRT-PCR) testing. As a proxy for contagiousness, viral culture was performed on a selection of qRT-PCR positive samples to determine the Ct-value at which the chance of a positive culture dropped below 0.5 (Ct-value cut-off). Sensitivity and specificity of self-testing were compared to qRT-PCR with a Ct-value below the Ct value cut-off. Determinants independently associated with a false-negative self-test result were determined. A total of 3201 participants were included (BD-RDT n = 1595; Roche-RDT n = 1606). Sensitivity and specificity of self-testing compared with the qRT-PCR results with a Ct-value below the Ct-value cut-off were 78.4% (95% CI 73.2%–83.5%) and 99.4% (95% CI 99.1%–99.7%), respectively. A higher age was independently associated with a false-negative self-testing result with an odds ratio of 1.024 (95% CI 1.003–1.044). Self-testing using currently available RDT has a high specificity and relatively high sensitivity to identify individuals with a high probability of contagiousness.</description><identifier>ISSN: 1198-743X</identifier><identifier>EISSN: 1469-0691</identifier><identifier>DOI: 10.1016/j.cmi.2021.07.039</identifier><identifier>PMID: 34363945</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Antigens, Viral - analysis ; Coronavirus disease 2019 ; COVID-19 - diagnosis ; COVID-19 Testing ; Humans ; Original ; Public health ; Rapid antigen detection test ; SARS-CoV-2 - genetics ; Self-Testing ; Sensitivity and Specificity ; Severe acute respiratory syndrome coronavirus 2</subject><ispartof>Clinical microbiology and infection, 2022-05, Vol.28 (5), p.695-700</ispartof><rights>2021 European Society of Clinical Microbiology and Infectious Diseases</rights><rights>Copyright © 2021 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.</rights><rights>2021 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. 2021 European Society of Clinical Microbiology and Infectious Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-638f8ca9af1d261b281dc4bdb5740bf2b1f24d084160641d3a2de171a51bc8b03</citedby><cites>FETCH-LOGICAL-c451t-638f8ca9af1d261b281dc4bdb5740bf2b1f24d084160641d3a2de171a51bc8b03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,782,786,887,27931,27932</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34363945$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stohr, Joep J.J.M.</creatorcontrib><creatorcontrib>Zwart, Vivian F.</creatorcontrib><creatorcontrib>Goderski, Gabriel</creatorcontrib><creatorcontrib>Meijer, Adam</creatorcontrib><creatorcontrib>Nagel-Imming, Carla R.S.</creatorcontrib><creatorcontrib>Kluytmans-van den Bergh, Marjolein F.Q.</creatorcontrib><creatorcontrib>Pas, Suzan D.</creatorcontrib><creatorcontrib>van den Oetelaar, Femke</creatorcontrib><creatorcontrib>Hellwich, Marloes</creatorcontrib><creatorcontrib>Gan, Kim H.</creatorcontrib><creatorcontrib>Rietveld, Ariene</creatorcontrib><creatorcontrib>Verweij, Jaco J.</creatorcontrib><creatorcontrib>Murk, Jean-Luc</creatorcontrib><creatorcontrib>van den Bijllaardt, Wouter</creatorcontrib><creatorcontrib>Kluytmans, Jan A.J.W.</creatorcontrib><title>Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community</title><title>Clinical microbiology and infection</title><addtitle>Clin Microbiol Infect</addtitle><description>To evaluate the performance of nasal mid-turbinate self-testing using rapid antigen detection tests (RDT) for persons with suspected coronavirus disease 2019 (COVID-19) in the community. Self-testing for COVID-19 infection with lateral flow assay severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RDT, provides rapid results and could enable frequent and extensive testing in the community, thereby improving the control of SARS-CoV-2. Participants visiting a municipal SARS-CoV-2 testing centre, received self-testing kits containing either the BD Veritor System (BD-RDT) or Roche SARS-CoV-2 antigen detection test (Roche-RDT). Oro-nasopharyngeal swabs were collected from the participants for quantitative RT-PCR (qRT-PCR) testing. As a proxy for contagiousness, viral culture was performed on a selection of qRT-PCR positive samples to determine the Ct-value at which the chance of a positive culture dropped below 0.5 (Ct-value cut-off). Sensitivity and specificity of self-testing were compared to qRT-PCR with a Ct-value below the Ct value cut-off. Determinants independently associated with a false-negative self-test result were determined. A total of 3201 participants were included (BD-RDT n = 1595; Roche-RDT n = 1606). Sensitivity and specificity of self-testing compared with the qRT-PCR results with a Ct-value below the Ct-value cut-off were 78.4% (95% CI 73.2%–83.5%) and 99.4% (95% CI 99.1%–99.7%), respectively. A higher age was independently associated with a false-negative self-testing result with an odds ratio of 1.024 (95% CI 1.003–1.044). Self-testing using currently available RDT has a high specificity and relatively high sensitivity to identify individuals with a high probability of contagiousness.</description><subject>Antigens, Viral - analysis</subject><subject>Coronavirus disease 2019</subject><subject>COVID-19 - diagnosis</subject><subject>COVID-19 Testing</subject><subject>Humans</subject><subject>Original</subject><subject>Public health</subject><subject>Rapid antigen detection test</subject><subject>SARS-CoV-2 - genetics</subject><subject>Self-Testing</subject><subject>Sensitivity and Specificity</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><issn>1198-743X</issn><issn>1469-0691</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUuLFDEUhYMoztj6A9xIlm6qzKseQRCG9jUwMGDr4C6k8uhOU5WUSWpk1v5x09PtoBtXuSTnfDf3HgBeYlRjhNs3-1pNriaI4Bp1NaL8ETjHrOUVajl-XGrM-6pj9PsZeJbSHiFEKGVPwRlltKWcNefg18aMtsomZee30IYI885AbbJR2QUPg4Wbiy-bah1uKgKdt6f7ny7vYJSz01D67LbGwwMk3SNmE-bRHDVpSXPxGA3X1zeX7yvMC-W-iQrTtHiX756DJ1aOybw4nSvw7eOHr-vP1dX1p8v1xVWlWINz1dLe9kpyabEmLR5Ij7Vigx6ajqHBkgFbwjTqGW5Ry7CmkmiDOywbPKh-QHQF3h258zJMRivjc5SjmKObZLwTQTrx74t3O7ENt6KntOX8AHh9AsTwYynjisklZcZRehOWJEjTcEYRK_oVwEepiiGlaOxDG4zEITyxFyU8cQhPoE6U8Irn1d__e3D8SasI3h4Fpmzp1pkoknLGK6NdLDsWOrj_4H8D9rasDQ</recordid><startdate>20220501</startdate><enddate>20220501</enddate><creator>Stohr, Joep J.J.M.</creator><creator>Zwart, Vivian F.</creator><creator>Goderski, Gabriel</creator><creator>Meijer, Adam</creator><creator>Nagel-Imming, Carla R.S.</creator><creator>Kluytmans-van den Bergh, Marjolein F.Q.</creator><creator>Pas, Suzan D.</creator><creator>van den Oetelaar, Femke</creator><creator>Hellwich, Marloes</creator><creator>Gan, Kim H.</creator><creator>Rietveld, Ariene</creator><creator>Verweij, Jaco J.</creator><creator>Murk, Jean-Luc</creator><creator>van den Bijllaardt, Wouter</creator><creator>Kluytmans, Jan A.J.W.</creator><general>Elsevier Ltd</general><general>European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220501</creationdate><title>Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community</title><author>Stohr, Joep J.J.M. ; Zwart, Vivian F. ; Goderski, Gabriel ; Meijer, Adam ; Nagel-Imming, Carla R.S. ; Kluytmans-van den Bergh, Marjolein F.Q. ; Pas, Suzan D. ; van den Oetelaar, Femke ; Hellwich, Marloes ; Gan, Kim H. ; Rietveld, Ariene ; Verweij, Jaco J. ; Murk, Jean-Luc ; van den Bijllaardt, Wouter ; Kluytmans, Jan A.J.W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-638f8ca9af1d261b281dc4bdb5740bf2b1f24d084160641d3a2de171a51bc8b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antigens, Viral - analysis</topic><topic>Coronavirus disease 2019</topic><topic>COVID-19 - diagnosis</topic><topic>COVID-19 Testing</topic><topic>Humans</topic><topic>Original</topic><topic>Public health</topic><topic>Rapid antigen detection test</topic><topic>SARS-CoV-2 - genetics</topic><topic>Self-Testing</topic><topic>Sensitivity and Specificity</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stohr, Joep J.J.M.</creatorcontrib><creatorcontrib>Zwart, Vivian F.</creatorcontrib><creatorcontrib>Goderski, Gabriel</creatorcontrib><creatorcontrib>Meijer, Adam</creatorcontrib><creatorcontrib>Nagel-Imming, Carla R.S.</creatorcontrib><creatorcontrib>Kluytmans-van den Bergh, Marjolein F.Q.</creatorcontrib><creatorcontrib>Pas, Suzan D.</creatorcontrib><creatorcontrib>van den Oetelaar, Femke</creatorcontrib><creatorcontrib>Hellwich, Marloes</creatorcontrib><creatorcontrib>Gan, Kim H.</creatorcontrib><creatorcontrib>Rietveld, Ariene</creatorcontrib><creatorcontrib>Verweij, Jaco J.</creatorcontrib><creatorcontrib>Murk, Jean-Luc</creatorcontrib><creatorcontrib>van den Bijllaardt, Wouter</creatorcontrib><creatorcontrib>Kluytmans, Jan A.J.W.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical microbiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stohr, Joep J.J.M.</au><au>Zwart, Vivian F.</au><au>Goderski, Gabriel</au><au>Meijer, Adam</au><au>Nagel-Imming, Carla R.S.</au><au>Kluytmans-van den Bergh, Marjolein F.Q.</au><au>Pas, Suzan D.</au><au>van den Oetelaar, Femke</au><au>Hellwich, Marloes</au><au>Gan, Kim H.</au><au>Rietveld, Ariene</au><au>Verweij, Jaco J.</au><au>Murk, Jean-Luc</au><au>van den Bijllaardt, Wouter</au><au>Kluytmans, Jan A.J.W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community</atitle><jtitle>Clinical microbiology and infection</jtitle><addtitle>Clin Microbiol Infect</addtitle><date>2022-05-01</date><risdate>2022</risdate><volume>28</volume><issue>5</issue><spage>695</spage><epage>700</epage><pages>695-700</pages><issn>1198-743X</issn><eissn>1469-0691</eissn><abstract>To evaluate the performance of nasal mid-turbinate self-testing using rapid antigen detection tests (RDT) for persons with suspected coronavirus disease 2019 (COVID-19) in the community. Self-testing for COVID-19 infection with lateral flow assay severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RDT, provides rapid results and could enable frequent and extensive testing in the community, thereby improving the control of SARS-CoV-2. Participants visiting a municipal SARS-CoV-2 testing centre, received self-testing kits containing either the BD Veritor System (BD-RDT) or Roche SARS-CoV-2 antigen detection test (Roche-RDT). Oro-nasopharyngeal swabs were collected from the participants for quantitative RT-PCR (qRT-PCR) testing. As a proxy for contagiousness, viral culture was performed on a selection of qRT-PCR positive samples to determine the Ct-value at which the chance of a positive culture dropped below 0.5 (Ct-value cut-off). Sensitivity and specificity of self-testing were compared to qRT-PCR with a Ct-value below the Ct value cut-off. Determinants independently associated with a false-negative self-test result were determined. A total of 3201 participants were included (BD-RDT n = 1595; Roche-RDT n = 1606). Sensitivity and specificity of self-testing compared with the qRT-PCR results with a Ct-value below the Ct-value cut-off were 78.4% (95% CI 73.2%–83.5%) and 99.4% (95% CI 99.1%–99.7%), respectively. A higher age was independently associated with a false-negative self-testing result with an odds ratio of 1.024 (95% CI 1.003–1.044). Self-testing using currently available RDT has a high specificity and relatively high sensitivity to identify individuals with a high probability of contagiousness.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>34363945</pmid><doi>10.1016/j.cmi.2021.07.039</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1198-743X
ispartof Clinical microbiology and infection, 2022-05, Vol.28 (5), p.695-700
issn 1198-743X
1469-0691
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8336990
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Antigens, Viral - analysis
Coronavirus disease 2019
COVID-19 - diagnosis
COVID-19 Testing
Humans
Original
Public health
Rapid antigen detection test
SARS-CoV-2 - genetics
Self-Testing
Sensitivity and Specificity
Severe acute respiratory syndrome coronavirus 2
title Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T13%3A55%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Self-testing%20for%20the%20detection%20of%20SARS-CoV-2%20infection%20with%20rapid%20antigen%20tests%20for%20people%20with%20suspected%20COVID-19%20in%20the%20community&rft.jtitle=Clinical%20microbiology%20and%20infection&rft.au=Stohr,%20Joep%20J.J.M.&rft.date=2022-05-01&rft.volume=28&rft.issue=5&rft.spage=695&rft.epage=700&rft.pages=695-700&rft.issn=1198-743X&rft.eissn=1469-0691&rft_id=info:doi/10.1016/j.cmi.2021.07.039&rft_dat=%3Cproquest_pubme%3E2559430483%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2559430483&rft_id=info:pmid/34363945&rft_els_id=S1198743X21004341&rfr_iscdi=true